Sponsor:
Children's Hospital Medical Center, Cincinnati
Code:
NCT06227780
Conditions
Fragile X Syndrome
Autism Spectrum Disorder
Autistic Disorder
Asperger Syndrome
Eligibility Criteria
Sex: All
Age: 5 - 10
Healthy Volunteers: Accepted
Interventions
Alpha Auditory Entrainment
Sham
Brief summary:
Conditions
Fragile X Syndrome
Autism Spectrum Disorder
Autistic Disorder
Asperger Syndrome
Study ID
NCT06227780
Start date
May 24, 2023
Status verified date
Mar, 2026
Completion date
May 24, 2028
Anticipated
Primary completion date
May 24, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 5 - 10
Healthy Volunteers: Accepted
Enrollment
180 participants
Anticipated
Allocation
Randomized
Intervention Model
Crossover
Primary purpose
Treatment
Arms
experimental: Fragile X Syndrome
active comparator: Autism Spectrum Disorder Controls
active comparator: Typically Developing Controls
Interventions
Alpha Auditory Entrainment
Sham
Primary outcome measure
Central contacts
Locations
Cincinnati Children's Hospital Medical Center
Recruiting
Cincinnati, Ohio, United States, 45226
Contacts
Grace Westerkamp
grace.westerkamp@cchmc.orgPrincipal Investigator:
Ernest V Pedapati, MD
Sponsor
Children's Hospital Medical Center, Cincinnati
Last update posted
Mar 30, 2026
Last verified
Mar, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-04. This information was provided to ClinicalTrials.gov by Children's Hospital Medical Center, Cincinnati on 2026-03-30.